The mitochondrial translocator protein (TSPO) in Alzheimer's disease: Therapeutic and immunomodulatory functions
Biochimie · 2024-09 · 224 · 120-131
DOI: 10.1016/j.biochi.2024.07.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimie, 2024-09. Verfasst von Lauren H Fairley und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 308232, Singapore. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptors, GABA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Demenz
Abstract (Originalsprache)
The translocator protein (TSPO) has been widely investigated as a PET-imaging biomarker of neuroinflammation and, more recently, as a therapeutic target for the treatment of neurodegenerative disease. TSPO ligands have been shown to exert neuroprotective effects in vivo and in vitro models of Alzheimer's disease (AD), by reducing toxic beta amyloid peptides, and attenuating brain atrophy. Recent transcriptomic and proteomic analyses, and the generation of TSPO-KO mice, have enabled new insights into the mechanistic function of TSPO in AD. Using a multi-omics approach in both TSPO-KO- and TSPO ligand-treated mice, we have demonstrated a key role for TSPO in microglial respiratory metabolism and phagocytosis in AD. In this review, we discuss emerging evidence for therapeutic and immunomodulatory functions of TSPO in AD, and new tools for studying TSPO in the brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 308232, Singapore.
- Transfaculty Research Platform, Molecular & Cognitive Neuroscience, Neurobiology Laboratory for Brain Aging and Mental Health, University of Basel, Basel, Switzerland; Psychiatric University Clinics, Basel, Switzerland.
- Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 308232, Singapore. Electronic address: barron@ntu.edu.sg.
Zitieren
APA
Fairley, L. H., Lai, K. O., Grimm, A., Eckert, A., & Barron, A. M. (2024). The mitochondrial translocator protein (TSPO) in Alzheimer's disease: Therapeutic and immunomodulatory functions. Biochimie, 224, 120-131. https://doi.org/10.1016/j.biochi.2024.07.003
Vancouver
Fairley LH, Lai KO, Grimm A, Eckert A, Barron AM. The mitochondrial translocator protein (TSPO) in Alzheimer's disease: Therapeutic and immunomodulatory functions. Biochimie. 2024;224:120-131. doi:10.1016/j.biochi.2024.07.003
BibTeX
@article{Fairley2024,
author = {Fairley, Lauren H and Lai, Kei Onn and Grimm, Amandine and Eckert, Anne and Barron, Anna M},
title = {The mitochondrial translocator protein (TSPO) in Alzheimer's disease: Therapeutic and immunomodulatory functions},
journal = {Biochimie},
year = {2024},
volume = {224},
pages = {120--131},
doi = {10.1016/j.biochi.2024.07.003}
}
EUVIMED